-
WHO says 172 economies in talks for access to COVID-19 vaccines programme
europeanpharmaceuticalreview
September 08, 2020
The WHO has announced that many economies worldwide may participate in COVAX, an initiative aimed at providing countries with equitable access to COVID-19 vaccines.
-
Russia’s Sputnik V COVID-19 vaccine safely elicits an antibody response, reports paper
europeanpharmaceuticalreview
September 08, 2020
Preliminary data from Phase I/II trails evaluating the vaccine reveal 100 percent of participants had a humoral and cellular response, with no serious adverse events reported.
-
UNICEF to pilot acquisition, distribution of COVID-19 vaccines
expresspharma
September 08, 2020
The effort, involving over 170 economies, has the potential to become the world's largest and fastest ever operation of its kind.
-
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
americanpharmaceuticalreview
September 07, 2020
Albany Molecular Research, Inc. (AMRI) has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus.
-
COVID-19 vaccine makers to prepare joint pledge for safety
expresspharma
September 07, 2020
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes.
-
CenExel Clinical Research Sites Tackle COVID-19 Vaccine Testing
americanpharmaceuticalreview
September 04, 2020
CenExel Centers of Excellence are participating in U.S. Operation Warp Speed projects to advance COVID-19 vaccine research quickly without sacrificing quality.
-
J&J’s Covid-19 vaccine prevents severe disease in preclinical tests
pharmaceutical-technology
September 04, 2020
Johnson & Johnson (J&J) has reported that a Covid-19 vaccine candidate, developed by the company’s subsidiary Janssen, prevented severe disease in preclinical studies.
-
Prep for COVID-19 vaccine distribution as soon as late October: US CDC
expresspharma
September 04, 2020
An earlier report had informed that the CDC had contacted officials in all 50 states and five large cities with the planning information.
-
Sanofi, GSK initiate Phase 1/2 clinical trial of COVID-19 vaccine candidate
expresspharma
September 04, 2020
440 participants are being enrolled in the trial across 11 investigational sites in the US, companies expect first results in early December 2020.
-
Canadian government strikes deals with Janssen and Novavax for COVID-19 vaccines
europeanpharmaceuticalreview
September 03, 2020
The Canadian government has agreed that Janssen will supply the country with 38 million doses of its COVID-19 vaccine, while Novavax has agreed to supply 76 million doses if its vaccine.